GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Float Percentage Of Total Shares Outstanding

Kadimastem (XTAE:KDST) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 16, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kadimastem's float shares is 0.00 Mil. Kadimastem's total shares outstanding is 4.19 Mil. Kadimastem's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kadimastem's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kadimastem's Institutional Ownership is 0.11%.

Kadimastem Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Kadimastem's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/4.19
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kadimastem (XTAE:KDST) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XTAE:XTLB XTAE:BOLT XTAE:PLNT XTAE:CANF XTAE:HDST-M XTAE:MTLF XTAE:CBI XTAE:DNA XTAE:EVGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE
Traded in Other Exchanges
KMSTF:USA
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Website
http://www.kadimastem.com
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines